Skip to content

Clinical trials

Phase 1 Diabetic Nephropathies trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Phase: Phase 1 Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20111
20151
20171
20192
20213
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Goldfinch Bio, Inc.2
AstraZeneca1
Boehringer Ingelheim1
Concert Pharmaceuticals1
Gilead Sciences1
Icahn School of Medicine at Mount Sinai1
Kalie Tommerdahl1
Kyntra Bio1
LaTonya J. Hickson1
Lisata Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies15
Diabetes Mellitus, Type 25
Renal Insufficiency, Chronic5
Diabetes Mellitus3
Diabetes Mellitus, Type 13
Diabetes Complications2
Endocrine System Diseases2
Kidney Diseases2
Proteinuria2
Cardiovascular Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.